BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27033473)

  • 1. Transcatheter arterial chemical infusion for advanced non-small-cell lung cancer: long-term outcome and predictor of survival.
    Fu YF; Li Y; Wei N; Xu H
    Radiol Med; 2016 Jul; 121(7):605-10. PubMed ID: 27033473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-arterial infusion chemotherapy for non-small cell lung carcinoma--significance of detecting feeding arteries and tumor staining.
    Nakanishi M; Demura Y; Umeda Y; Mizuno S; Ameshima S; Chiba Y; Ishizaki T
    Lung Cancer; 2008 Aug; 61(2):227-34. PubMed ID: 18243405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of transarterial infusion of docetaxel and cisplatin to treat non-small-cell lung cancer in patients contraindicated for standard chemotherapy.
    Nakanishi M; Yoshida Y; Natazuka T
    Lung Cancer; 2012 Aug; 77(2):353-8. PubMed ID: 22537620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
    Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
    AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of non-small-cell lung cancer by dual (bronchial and pulmonary) arterial drug infusion].
    Shi W; Zhang S; Zhang X
    Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):146-8. PubMed ID: 7656809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination chemotherapy with Taxol and cisplatin for 57 patients with non-small cell lung cancer by intraartery and intravenous infusion].
    Zhao Y; Wang SM; Zhang J
    Ai Zheng; 2002 Dec; 21(12):1365-7. PubMed ID: 12520750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the efficacy of bronchial arterial infusion chemotherapy for the treatment of central non-small cell lung cancer].
    Yan D; Zhou CW; Liu DZ; Chen Y; Zeng HY; Li H
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):302-4. PubMed ID: 21575505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of whole-tumor dual-input perfusion CT in predicting the effect of multiarterial infusion chemotherapy on advanced non-small cell lung cancer.
    Li XS; Fan HX; Fang H; Huang H; Song YL; Zhou CW
    AJR Am J Roentgenol; 2014 Nov; 203(5):W497-505. PubMed ID: 25341164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical observation on treatment of non-small cell lung cancer with Chinese herbal medicine combined with bronchial arterial infusion chemotherapy].
    Liu CL; Wang YD; Jin XJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Aug; 21(8):579-81. PubMed ID: 12575569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the enhancer of zeste homolog 2 in biopsy specimen predicts chemoresistance and survival in advanced non-small cell lung cancer receiving first-line platinum-based chemotherapy.
    Xu C; Hao K; Hu H; Sheng Z; Yan J; Wang Q; Yu L
    Lung Cancer; 2014 Nov; 86(2):268-73. PubMed ID: 25262426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined arterial infusion and stent implantation compared with metal stent alone in treatment of malignant gastroduodenal obstruction.
    Wang Z; Chen K; Gong J; Zheng Y; Wang T
    Cardiovasc Intervent Radiol; 2009 Sep; 32(5):1011-8. PubMed ID: 19669831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of oleum fructus brucease injection via bronchial arterial infusion in treating advanced lung cancer].
    Bai ZP; Deng XS
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Aug; 30(8):838-40. PubMed ID: 21038653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic arterial infusion chemotherapy with use of an implanted port system in patients with advanced hepatocellular carcinoma: prognostic factors.
    Hamada A; Yamakado K; Nakatsuka A; Takaki H; Akeboshi M; Takeda K
    J Vasc Interv Radiol; 2004 Aug; 15(8):835-41. PubMed ID: 15297587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of paclitaxel by 96-hour continuous infusion in combination with cisplatin for patients with advanced non-small cell lung cancer.
    Breathnach OS; Georgiadis MS; Schuler BS; Pizzella P; Llorens V; Kasturi V; Steinberg SM; O'Neil K; Takimoto CH; Johnson BE
    Clin Cancer Res; 2000 Jul; 6(7):2670-6. PubMed ID: 10914708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma.
    Nishikawa H; Osaki Y; Kita R; Kimura T; Ohara Y; Takeda H; Sakamoto A; Saito S; Nishijima N; Nasu A; Komekado H; Nishiguchi S
    Oncol Rep; 2014 Jan; 31(1):65-72. PubMed ID: 24220763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?
    Choi YW; Ahn MS; Jeong GS; Lee HW; Jeong SH; Kang SY; Park JS; Choi JH; Lee SY
    Lung Cancer; 2015 Feb; 87(2):155-61. PubMed ID: 25488862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is ¹⁸F-fluorodeoxyglucose positron emission tomography-based metabolic response superior to Response Evaluation Criteria In Solid Tumors-based response after two cycles of platinum-based chemotherapy in predicting clinical outcome of untreated patients with advanced non-small cell lung cancer?
    Yang JJ; Wang SX; Zhong WZ; Xu CR; Yan HH; Wu YL
    Nucl Med Commun; 2011 Dec; 32(12):1113-20. PubMed ID: 21934546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transcatheter hepatic artery infusion chemotherapy and embolization for 60 patients with primary hepatic carcinoma].
    Li GQ
    Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):33-6. PubMed ID: 1653688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective use of multi-arterial infusion chemotherapy for advanced non-small cell lung cancer patients: four clinical specified cases.
    Nakanishi M; Umeda Y; Demura Y; Ameshima S; Chiba Y; Miyamori I; Ishizaki T
    Lung Cancer; 2007 Feb; 55(2):241-7. PubMed ID: 17098326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
    Costa GJ; Fernandes AL; Pereira JR; Curtis JR; Santoro IL
    Lung Cancer; 2006 Aug; 53(2):171-6. PubMed ID: 16757059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.